These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain. Luna RA; Millecker LA; Webb CR; Mason SK; Whaley EM; Starke JR; Hiatt PW; Versalovic J J Clin Microbiol; 2013 Apr; 51(4):1237-40. PubMed ID: 23303498 [TBL] [Abstract][Full Text] [Related]
12. Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals. Telling K; Laht M; Brauer A; Remm M; Kisand V; Maimets M; Tenson T; Lutsar I BMC Infect Dis; 2018 Oct; 18(1):513. PubMed ID: 30309321 [TBL] [Abstract][Full Text] [Related]
13. Draft genome sequence of an aminoglycoside-resistant RmtG-producing Pseudomonas aeruginosa ST235 isolated from a cystic fibrosis patient. Bueno MFC; Francisco GR; Cerdeira L; Ienne S; Souza TA; Lincopan N; de Oliveira Garcia D J Glob Antimicrob Resist; 2017 Mar; 8():106-107. PubMed ID: 28082143 [TBL] [Abstract][Full Text] [Related]
14. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa. Nakamura A; Miyake K; Misawa S; Kuno Y; Horii T; Kondo S; Tabe Y; Ohsaka A J Hosp Infect; 2013 Feb; 83(2):153-5. PubMed ID: 23201400 [TBL] [Abstract][Full Text] [Related]
15. Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic. Nemec A; Krizova L; Maixnerova M; Musilek M Res Microbiol; 2010 Apr; 161(3):234-42. PubMed ID: 20156555 [TBL] [Abstract][Full Text] [Related]
16. [Epidemiology and drug susceptibility of Pseudomonas aeruginosa strains isolated in the Chugoku region of Japan. Infection Forum in the Chugoku Region]. Kuwabara M; Kusano N; Shimizu E; Shimizu W; Kobayashi K; Koda S; Doi M; Sugai M; Kumon H Jpn J Antibiot; 2011 Apr; 64(2):97-108. PubMed ID: 21721248 [TBL] [Abstract][Full Text] [Related]
17. Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea. Lee JY; Song JH; Ko KS Microb Drug Resist; 2011 Jun; 17(2):299-304. PubMed ID: 21381965 [TBL] [Abstract][Full Text] [Related]
18. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital. Çekin ZK; Dabos L; Malkoçoğlu G; Fortineau N; Bayraktar B; Iorga BI; Naas T; Aktaş E Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808 [TBL] [Abstract][Full Text] [Related]
19. Outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit. Durojaiye OC; Carbarns N; Murray S; Majumdar S J Hosp Infect; 2011 Jun; 78(2):154-5. PubMed ID: 21507523 [No Abstract] [Full Text] [Related]